Collaborations, Competitor News

Five Leading Real-World Data and Analytics Organizations Join the RWE Alliance, Doubling Membership

April 05, 2022 07:00 AM Eastern Daylight Time WASHINGTON–(BUSINESS WIRE)–The RWE Alliance is pleased to announce the addition of five new members—ConcertAI, OM1, Syneos Health, Verana Health, and Verily—to continue to advance policies to support regulatory use of real-world evidence (RWE). The RWE Alliance is a policy and advocacy coalition of real-world data (RWD) and analytics…

AI, Collaborations, Competitor News, Oncology, Pharma

PathAI and GlaxoSmithKline Sign Multi-Year Agreement to Accelerate Research and Drug Development

April 05, 2022 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–PathAI, a global leader in AI-powered pathology, and GlaxoSmithKline (GSK), today announced a strategic multi-year partnership to accelerate scientific research and drug development programs in oncology and non-alcoholic steatohepatitis (NASH) by leveraging PathAI’s technologies in digital pathology including the use of PathAI’s…

Collaborations, Competitor News, COVID-19, Data Partnership, RWE Study

Blood Cancer Journal Study Finds Multiple Myeloma Patients at Higher Risk of COVID-19 Infection and Mortality

Cambridge, MA, April 4, 2022 â€” TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, enabled researchers at Hospital Universitario 12 de Octubre to leverage European real-world data for a study that found that multiple myeloma (MM) patients were more likely to contract…

Collaborations, Competitor News, Data Partnership, Pharma, RWE Study

Mitsubishi Tanabe Pharma America Presents Real-World Data on RADICAVA® (edaravone) at 2022 American Academy of Neurology Annual Meeting

Analysis Suggests Use of RADICAVA IV is Associated with Improved Survival in People with ALS JERSEY CITY, N.J., April 4, 2022  /PRNewswire/ — Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of an analysis of real-world data that suggest continued treatment of amyotrophic lateral sclerosis (ALS) patients with intravenous (IV)…

Collaborations, Competitor News, Data Partnership, Pharma, RWE Study

New Data at AAN 2022 Highlight Real-World Evidence from Biogen’s MS Portfolio and Emerging Research on Disease Progression

Data from NOVA study further support the efficacy and safety of natalizumab IV when administered every six weeks as compared to the approved every four-week dosing Additional real-world data affirm high rates of persistence and adherence for VUMERITY® (diroximel fumarate) Early research investigates the potential of machine learning to predict MS…

Collaborations, Competitor News

ATCC Announces Expansion of its Bioinformatics Data Platform with QIAGEN

ATCC’s collection of high-fidelity authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research purposes.April 04, 2022 08:00 AM Eastern Daylight Time MANASSAS, Va.–(BUSINESS WIRE)–ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an…

Collaborations, Industry News

Digital Medicine Society Launches Toolkit to Support Reimbursement for New Drugs Developed Using Digital Endpoints

BOSTON , April 4, 2022 /PRNewswire/ — Today, the Digital Medicine Society (DiMe), in partnership with Anthem, Biogen, Eli Lilly, Evidation, Janssen, Merck, Pfizer, and Savvy Co-op, announced the public launch of the 3Ps of Digital Endpoint Value (3Ps), a toolkit of resources created to facilitate the inclusion of digital endpoints as evidence for payers in…

Competitor News, Product Updates

Verana Health Launches Neurology Qdata™ Insights Offerings at American Academy of Neurology Annual Meeting

First disease-specific data module in neuroscience, Qdata™SMA, helps power exclusive real-world evidence generation into a rare-disease patient journey from one of world’s largest clinical neurology data registries SAN FRANCISCO — April 4, 2022 â€” Verana Health®—a digital health company that delivers quality drug lifecycle and medical practice insights from an exclusive real-world…

Collaborations, Competitor News, Oncology

Guardant Health Announces Partnership with Epic to Streamline Access to Company’s Broad Portfolio of Cancer Tests

April 04, 2022 08:05 AM Eastern Daylight Time REDWOOD CITY, Calif.–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a partnership with Epic, the nation’s most widely used comprehensive health record, to integrate the company’s broad portfolio of cancer tests with Epic. This integration will make…

Government/Regulatory, Industry News

NHS England plans federated data platform

NHS England is laying plans for the development of a federated data platform. It has published a prior information notice for potential suppliers, indicating that the procurement could have a total value of £240 million. The move reflects the long running trend towards the increased integration of systems and data sharing around…